MannKind Corp to Discuss the Purchase of Tyvaso DPI by Sagard Healthcare Transcript
Good morning and welcome to the Mankind Corporation conference call regarding the Royalty Sale Agreement announced yesterday, January 2, 2024. As a reminder, this call is being recorded on January 3, 2024 and will be available for playback on the Mannkind Corporation website shortly after the conclusion of this call until January 17, 2024.
This call will contain forward-looking statements. Such forward-looking statements are subject to risk and uncertainty, which could cause actual results to differ materially from these stated expectations. For further information on the company's risk factors, please see their recent 10-Q report filed with the US Securities Exchange Commission and the slides prepared for this presentation.
Joining us this morning from Mannkind are Chief Executive Officer Michael Castagna and Chief Financial Officer Steven Binder. We will not be taking any questions after Mr. Castagna and Mr. Binder have completed their remarks. I would now like to turn the conference over to Mr. Castagna. Please go ahead, sir.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
